Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate hypersensitivity reactions to paclitaxel-based chemotherapy in gynecologic cancer patients
TCTR20200220001Completed
- Sponsor
- No
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of paclitaxel in gynecological cancer, sponsored by No. Primary endpoints: Incidence of immediate hypersensitivity reactions, Clinical patterns of hypersensitivity reactions and 2 more. Started Feb 2019; status: completed.
02
Drugs
paclitaxel
03
Conditions
gynecological cancer
Beyond the preview
Go deeper on TCTR20200220001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200220001.